受强制性开放获取政策约束的文章 - Michael A Chapman了解详情
可在其他位置公开访问的文章：24 篇
Initial genome sequencing and analysis of multiple myeloma
MA Chapman, MS Lawrence, JJ Keats, K Cibulskis, C Sougnez, ...
Nature 471 (7339), 467-472, 2011
强制性开放获取政策： US National Institutes of Health
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy
JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo, MS Lawrence, D Auclair, ...
Cancer cell 25 (1), 91-101, 2014
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma
N Bolli, Y Li, V Sathiaseelan, K Raine, D Jones, P Ganly, F Cocito, ...
Blood cancer journal 6 (9), e467-e467, 2016
强制性开放获取政策： US National Institutes of Health, Wellcome Trust
Applications of next-generation sequencing to blood and marrow transplantation
M Chapman, EH Warren III, CJ Wu
Biology of Blood and Marrow Transplantation 18 (1), S151-S160, 2012
强制性开放获取政策： US National Institutes of Health
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma
GSF Anderson, J Ballester-Beltran, G Giotopoulos, JA Guerrero, S Surget, ...
Blood, The Journal of the American Society of Hematology 139 (16), 2471-2482, 2022
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
JC Yam-Puc, Z Hosseini, EC Horner, PP Gerber, N Beristain-Covarrubias, ...
Nature Communications 14 (1), 3292, 2023
强制性开放获取政策： German Research Foundation, Cancer Research UK, UK Medical Research Council …
The exocyst complex is an essential component of the mammalian constitutive secretory pathway
C Pereira, D Stalder, GSF Anderson, AS Shun-Shion, J Houghton, ...
Journal of Cell Biology 222 (5), e202205137, 2023
强制性开放获取政策： UK Biotechnology and Biological Sciences Research Council, UK Medical …
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study
M Camilleri, M Cuadrado, E Phillips, W Wilson, R Jenner, G Pang, ...
British Journal of Haematology 193 (4), 750-760, 2021
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
MA Chapman, J Sive, J Ambrose, C Roddie, N Counsell, A Lach, ...
Blood, The Journal of the American Society of Hematology 132 (20), 2154-2165, 2018
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, Wellcome Trust
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly …
K Yong, W Wilson, RM de Tute, M Camilleri, K Ramasamy, M Streetly, ...
The Lancet Haematology 10 (2), e93-e106, 2023
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol …
KL Royle, AB Coulson, K Ramasamy, DA Cairns, A Hockaday, ...
BMJ open 12 (11), e063037, 2022
强制性开放获取政策： Cancer Research UK
COVID‐19 and myeloma clinical research–experience from the CARDAMON clinical trial
M Camilleri, J Sive, W Wilson, G Pang, R Jenner, E Phillips, R Popat, ...
British journal of haematology 192 (1), e14, 2020
强制性开放获取政策： Cancer Research UK, UK Engineering and Physical Sciences Research Council …
Intratumoral antigen signaling traps CD8+ T cells to confine exhaustion to the tumor site
M Takahashi, TY So, V Chamberlain-Evans, R Hughes, JC Yam-Puc, ...
Science Immunology 9 (95), eade2094, 2024
强制性开放获取政策： Bill & Melinda Gates Foundation, Cancer Research UK, UK Medical Research …
T-cell redirecting therapies in haematological malignancies: current developments and novel strategies for improved targeting
GSF Anderson, MA Chapman
Molecular Therapy, 2024
强制性开放获取政策： UK Medical Research Council
Eukaryotic initiation factor 4B is a multi-functional RNA binding protein that regulates histone mRNAs
A Quintas, RF Harvey, E Horvilleur, GD Garland, T Schmidt, L Kalmar, ...
Nucleic Acids Research 52 (19), 12039-12054, 2024
强制性开放获取政策： UK Biotechnology and Biological Sciences Research Council, Cancer Research …
RADAR Trial: MRD Response Adapted Trial for Newly Diagnosed Transplant Eligible Myeloma Patients
K Ramasamy, DA Cairns, KL Royle, R Cicero, C Olivier, L Barnard, ...
Blood 142, 3390, 2023
强制性开放获取政策： Cancer Research UK
Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach
IG Walker, JP Roy, GSF Anderson, J Guerrero Lopez, MA Chapman
Leukemia, 1-5, 2024
强制性开放获取政策： UK Medical Research Council
Machine learning from the CARDAMON trial identifies a carfilzomib-specific mutational response signature
IG Walker, V D’arcy, G Khandelwal, G Anderson, A Aubareda, W Wilson, ...
medRxiv, 2023.04. 08.23288287, 2023
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
Cell surface proteomics reveal a strategy for targeting myeloma through combinatorial targeting of TNFRSF8 and TMPRSS11E
GSF Anderson, IG Walker, JP Roy, MA Chapman
bioRxiv, 2023.04. 04.535580, 2023
强制性开放获取政策： UK Medical Research Council
CAR-T cell therapies for cancer: what novel technologies are being developed for toxicity data?
W Parol, GSF Anderson, MA Chapman
Expert Opinion on Drug Metabolism & Toxicology 18 (4), 241-244, 2022
强制性开放获取政策： UK Medical Research Council
出版信息和资助信息由计算机程序自动确定